Beacon Capital Management LLC (Tennessee)’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.4K | Hold |
23,905
| – | – | 0.01% | 331 |
|
|
2025
Q1 | $29.2K | Hold |
23,905
| – | – | ﹤0.01% | 407 |
|
|
2024
Q4 | $30.8K | Hold |
23,905
| – | – | ﹤0.01% | 386 |
|
|
2024
Q3 | $65.7K | Hold |
23,905
| – | – | 0.01% | 278 |
|
|
2024
Q2 | $54K | Hold |
23,905
| – | – | 0.01% | 274 |
|
|
2024
Q1 | $57.1K | Hold |
23,905
| – | – | 0.01% | 272 |
|
|
2023
Q4 | $45.9K | Buy |
23,905
+11,300
| +90% | +$21.7K | 0.01% | 234 |
|
|
2023
Q3 | $18.2K | Hold |
12,605
| – | – | ﹤0.01% | 426 |
|
|
2023
Q2 | $18.2K | Hold |
12,605
| – | – | ﹤0.01% | 426 |
|
|
2023
Q1 | $26.5K | Hold |
12,605
| – | – | 0.01% | 321 |
|
|
2022
Q4 | $14.2K | Buy |
+12,605
| New | +$14.2K | ﹤0.01% | 433 |
|